Products: neuro-robot. Risk band: Elevated RobotRisk index 22.6/100 (incidents/exposure, time-weighted) · 94th percentile of 162 medical robotics companies.
The record contains two entries: a 2024 malfunction in which brain-implant threads retracted in the first human trial patient, and a 2022 federal inquiry into animal deaths during preclinical implant testing. Severity is 3 and 4 respectively, and the two entries span both a device-performance malfunction in human use and a federal investigative action tied to earlier preclinical work. The index of 21.4 and 94.4th percentile place the company in the elevated band within medical-robotics. The record shows two distinct failure types at different stages of development (preclinical animal testing and first-in-human deployment) rather than a single repeated fault.
| Sev | Date | Type | Location | Incident | Source |
|---|---|---|---|---|---|
| S3 | 05/08 2024 |
malfunction | — | Neuralink brain implant threads retract in first human patient | CBS News |
| S4 | fatality | — | Federal inquiry into Neuralink over animal deaths in implant testing | The Guardian |